Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Purple Biotech
Purple Biotech
(PPBT)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Annual sales USD (in millions)
Mock data
Subscribe for the real data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Consensi
Celecoxib
,
Amlodipine besylate
2018-05-31
2029-2038
Ankylosing spondylitis
,
Rheumatoid arthritis
,
Osteoarthritis
,
Adenomatous polyposis coli
,
Dysmenorrhea
,
Hypertension
,
Coronary artery disease
,
Variant angina pectoris
,
Pain
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Xenograft
carcinoma
,
head and neck neoplasms
,
squamous cell carcinoma of head and neck
,
squamous cell carcinoma
NT-219
head and neck neoplasms
,
squamous cell carcinoma of head and neck
,
colorectal neoplasms
,
neoplasms
,
carcinoma
,
squamous cell carcinoma
Mk3475
melanoma
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use